Back to Journals » Infection and Drug Resistance » Volume 11

Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints

Total article views   HTML views PDF downloads Totals
11,215 Dovepress* 9,669+ 1,313 10,982
PubMed Central* 1,546 203 1,749
Totals 11,215 1,516 12,731
*Since 25 May 2018
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar